Heart disease. Presence of aortocoronary bypass graft
Conditions
Interventions
Intervention 1: Intervention 1) Morphine sulfate 10 mg rectal suppository (Statex ,Pharmascience co. montreal Canada), can repeat every 4 hours if needed. Intervention 2: Intervention 1) Diclofenac S
Treatment - Drugs
Intervention 1) Morphine sulfate 10 mg rectal suppository (Statex ,Pharmascience co. montreal Canada), can repeat every 4 hours if needed.
Intervention 1) Diclofenac Sodium 50 mg rectal suppository (Aburaihan pharmaceutical Co. Iran), can repeat every 4 hours if needed.
Sponsors
Vice chancellor for research of Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: All patients that underwent elective CABG (Coronary artery bypass grafting ) that are not addicts and are ASA class 1 and 2 and are not allergic to the type of medications used and do not have history of COPD (Chronic obstructive-pulmonary disease) or asthma are studied. Exclusion criteria: All ICU patients that needed to undergo balloon pump or Inotropic therapy and those who received pain medications prior to extubation, those who were not alert and oriented enough and those that were uncooperative to determine VAS.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: every 4 hours after Intervention in 24 hours. Method of measurement: measure Vas. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactValli Imantalab
Guilan University of Medical Sciences
Outcome results
None listed